Our Mission:

Inspired by the concept of neuronal “synapses”, the SYNAPSE Research Program aims to solve clinical and scientific puzzles by connecting innovation and technology, physiology and pathology, gene and environment, health and disease. We also aim to bridge Eastern medicine and Western medicine.

Our Goal:

Autism Spectrum Disorder (ASD) is not just a disorder of the brain. We are committed to better understand the biological mechanism for autism and develop early screening tools and optimize effective therapies to improve patient lives with the disorder.

For more information https://www.nmr.mgh.harvard.edu/lab/synapse

Our Studies:

WHO:
We are currently recruiting for:
New studies coming soon
Data Analysis:
EARLY SCREENING FOR ASD:
1-6 years old high risk children

ASD CLINICAL TRIAL:
3-25 years old individuals with autism spectrum disorder

PRADER WILLI SYNDROME:
Individuals of all ages with PWS

WHEN:
We accommodate busy schedules by offering weekday, evening, and weekend appointments
We will work with your availability

WHERE:
MGH sites in Charlestown, MA

We offer compensation for time and travel and a summary report of results